SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000921895-09-000355
Filing Date
2009-02-06
Accepted
2009-02-06 17:25:08
Documents
1
Effectiveness Date
2009-02-06

Document Format Files

Seq Description Document Type Size
1 dfan14a07422003_02062009.htm DFAN14A 45071
  Complete submission text file 0000921895-09-000355.txt   47053
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A
SIC: 6282 Investment Advice

Mailing Address 1301 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1301 HARBOR BAY PARKWAY . ALAMEDA CA 94502 5107487150
AVIGEN INC \DE (Subject) CIK: 0000932903 (see all company filings)

IRS No.: 133647119 | State of Incorp.: DE | Fiscal Year End: 1121
Type: DFAN14A | Act: 34 | File No.: 000-28272 | Film No.: 09578293
SIC: 2835 In Vitro & In Vivo Diagnostic Substances